Computational techniques are used in computer-aided drug design to find, develop, and study drugs and other physiologically active compounds. The ligand-based computer-aided drug discovery (LB-CADD) method examines ligands that have been shown to interact with a target of interest. Computer-aided drug design (CADD) is a broad term that refers to a variety of theoretical and computational methodologies used in modern drug development. CADD approaches have aided in the creation of medications that are currently in use or are through clinical testing. Along with the experimental procedures employed in drug creation, such methods have emerged and evolved. Millions of drug compounds (virtual screening) and drug targets (protein receptors, enzymes, kinases, signalling proteins, and so on) can be screened using CADD.
Title : Advances in plasma-based waste treatment for sustainable communities
Hossam A Gabbar, Ontario Tech University, Canada
Title : Nanostructured biodevices based on carbon nanotubes and glyconanoparticles for bioelectrocatalytic applications
Serge Cosnier, Silesian University of Technology, Poland
Title : Carbon capture and storage: The impact of impurities in CO2 streams
Andy Brown, Progressive Energy Ltd, United Kingdom
Title : Supramolecular nano chemistries: Fighting viruses, inhibiting bacteria and growing tissues
Thomas J Webster, Hebei University of Technology, China
Title : Chemical engineering of vanadium and tantalum zeolites for application in environmental catalysis
Stanislaw Dzwigaj, Sorbonne Universite, France
Title : Disrupting TNF-α and TNFR1 interaction: Computational insights into the potential of D-Pinitol as an anti-inflammatory therapeutic
Ferran Acuna Pares, Universidad Internacional de la Rioja (UNIR), Spain